dicloxacillin has been researched along with prednisone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rasmussen, JE | 1 |
| Leyden, JJ; Rudolph, RI; Schwartz, W | 1 |
| Criollo-Palacios, F; Diaz-Perez, JA; Messa-Botero, O; Prieto-Bletan, A; Raju, S; Romero-Rojas, AE | 1 |
1 review(s) available for dicloxacillin and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for dicloxacillin and prednisone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Toxic epidermal necrolysis. A review of 75 cases in children.
Topics: Ampicillin; Child, Preschool; Dicloxacillin; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Penicillins; Prednisone; Racial Groups; Staphylococcal Infections; Staphylococcus aureus; Stevens-Johnson Syndrome | 1975 |
Treatment of staphylococcal toxic epidermal necrolysis.
Topics: Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Cortisone; Dexamethasone; Dicloxacillin; Erythromycin; Female; Glucocorticoids; Humans; Hydrocortisone; Infant; Infant, Newborn; Injections, Intravenous; Length of Stay; Male; Nafcillin; Prednisone; Staphylococcal Infections; Stevens-Johnson Syndrome; Time Factors | 1974 |
Primary diffuse large B-cell lymphoma associated with chronic osteomyelitis of the knee.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Dicloxacillin; Doxorubicin; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Knee Joint; Lymphoma, Large B-Cell, Diffuse; Osteomyelitis; Prednisone; Radiography; Rituximab; Vincristine | 2014 |